A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide plus Letrozole, and (3) Everolimus plus EDT in Patients with Unresectable Fibrolamellar Carcinoma

导出原文传递

翻译打印收藏纠错

作者： El Dika, Imane ^[1] ; Mayer, Robert J. ^[2] ; Venook, Alan P. ^[3] ; Capanu, Marinela ^[4] ; LaQuaglia, Michael P. ^[5] ; Kobos, Rachel ; O'Neill, Allison F. ; Chou, Joanne F. ; Ly, Michele ; Ang, Celina ; O'Reilly, Eileen ; Gordan, John D. ; Abou-Alfa, Ghassan K.

作者单位： Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA ^[1] Mem Sloan Kettering Canc Ctr, 300 East 66th St, New York, NY 10065 USA ^[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA ^[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA ^[4] Univ Calif San Francisco, San Francisco, CA 94143 USA ^[5]

发布时间 2021-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

The oncologist

2020年25卷11期

925-926页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide plus Letrozole, and (3) Everolimus plus EDT in Patients with Unresectable Fibrolamellar Carcinoma

The oncologist

相似文献

The oncologist

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide plus Letrozole, and (3) Everolimus plus EDT in Patients with Unresectable Fibrolamellar Carcinoma

The oncologist

相似文献

The oncologist

相关期刊

检索历史清除